Quarterly report pursuant to Section 13 or 15(d)

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED)

v3.23.1
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (UNAUDITED) - USD ($)
$ in Thousands
Total
As Restated
Series A Preferred
Common Stock
Additional Paid in Capital
Accumulated Deficit
Accumulated Other Comprehensive Deficit
Beginning balance at Jan. 02, 2021 $ 2,366     $ 2 $ 39,869 $ (36,917) $ (588)
Beginning balance, shares at Jan. 02, 2021     259,729 1,829,982      
Shares issued 5,544       5,544    
Shares issued, shares       571,428      
Share based compensation 109       109    
Stock option exercise 11       11    
Stock option exercise, shares       2,000      
Other comprehensive income (42)           (42)
Net income (loss) 502         502  
Ending balance at Apr. 03, 2021 8,490     $ 2 45,533 (36,415) (630)
Ending balance, shares at Apr. 03, 2021     259,729 2,403,410      
Beginning balance at Jan. 02, 2021 2,366     $ 2 39,869 (36,917) (588)
Beginning balance, shares at Jan. 02, 2021     259,729 1,829,982      
Net income (loss) (4,477)            
Ending balance at Jul. 03, 2021 3,598     $ 2 45,620 (41,394) (630)
Ending balance, shares at Jul. 03, 2021     259,729 2,407,410      
Beginning balance at Jan. 02, 2021 $ 2,366     $ 2 39,869 (36,917) (588)
Beginning balance, shares at Jan. 02, 2021     259,729 1,829,982      
Stock option exercise, shares 6,000            
Ending balance at Jan. 01, 2022 $ (8,676) $ (8,676)   $ 2 45,743 (53,804) (617)
Ending balance, shares at Jan. 01, 2022     238,729 2,827,410      
Beginning balance at Apr. 03, 2021 8,490     $ 2 45,533 (36,415) (630)
Beginning balance, shares at Apr. 03, 2021     259,729 2,403,410      
Share based compensation 71       71    
Stock option exercise 16       16    
Stock option exercise, shares       4,000      
Net income (loss) (4,979)         (4,979)  
Ending balance at Jul. 03, 2021 3,598     $ 2 45,620 (41,394) (630)
Ending balance, shares at Jul. 03, 2021     259,729 2,407,410      
Beginning balance at Jan. 01, 2022 (8,676) (8,676)   $ 2 45,743 (53,804) (617)
Beginning balance, shares at Jan. 01, 2022     238,729 2,827,410      
Share based compensation   4     4    
Other comprehensive income   (49)       (8) (41)
Net income (loss)   1,211       1,211  
Ending balance at Apr. 02, 2022   (7,510)   $ 2 45,747 (52,601) (658)
Ending balance, shares at Apr. 02, 2022     238,729 2,827,410      
Beginning balance at Jan. 01, 2022 $ (8,676) (8,676)   $ 2 45,743 (53,804) (617)
Beginning balance, shares at Jan. 01, 2022     238,729 2,827,410      
Net income (loss)   10,085          
Ending balance at Jul. 02, 2022   1,405   $ 2 45,747 (43,727) (617)
Ending balance, shares at Jul. 02, 2022     222,588 3,150,230      
Beginning balance at Apr. 02, 2022   (7,510)   $ 2 45,747 (52,601) (658)
Beginning balance, shares at Apr. 02, 2022     238,729 2,827,410      
Series A-1 preferred converted, Shares     (16,141) 322,820      
Other comprehensive income   41         41
Net income (loss)   8,874       8,874  
Ending balance at Jul. 02, 2022   $ 1,405   $ 2 $ 45,747 $ (43,727) $ (617)
Ending balance, shares at Jul. 02, 2022     222,588 3,150,230